Biotech | March 10, 2022
Pfizer initiates Phase2/3 study of Paxlovid in pediatric participants
Paxlovid is the first oral therapy specifically designed to combat Covid-19 to be evaluated in a pediatric clinical study
Paxlovid is the first oral therapy specifically designed to combat Covid-19 to be evaluated in a pediatric clinical study
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
Routine tests undertaken by women dropped by 35% in 2020
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Women's health is in fact a direct reflection of the nation's overall health
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Subscribe To Our Newsletter & Stay Updated
